结缔组织病患者完整降胸主动脉瘤腔内修复与开放手术修复的中期结局
利用TriNetX数据库回顾性比较结缔组织病合并完整降胸主动脉瘤患者接受TEVAR或开放手术的5年结局,匹配后各46例。TEVAR组仅再次血管内干预发生率显著更高(27.1% vs 4.8%,P=0.009),其他不良结局数值更高但无统计学显著差异。作者认为需要更大样本研究确定TEVAR的安全性和有效性。
要点
- 匹配后TEVAR组再次血管内干预发生率显著高于开放手术组(27.1% vs 4.8%,P=0.009)。
- TEVAR组其他不良结局发生率及风险数值上更高,但差异无统计学显著。
- 作者认为需要更大样本研究确定TEVAR在结缔组织病患者完整降胸主动脉瘤中的安全性和有效性。
核心结论
- TEVAR组不良结局发生率数值上高于开放手术组,但仅再次干预率差异有统计学显著。
- 鉴于腔内干预的不断发展,需要更大样本研究确定TEVAR在特定结缔组织病患者完整降胸主动脉瘤中的安全性和有效性。
研究设计与样本
- 纳入结缔组织病合并完整降胸主动脉瘤、初始接受TEVAR或开放手术的患者,按人口学、手术史和合并症等术前协变量进行1:1倾向评分匹配。
- 识别TEVAR组55例、开放手术组200例,匹配后每组各46例。
- 采用Kaplan-Meier法和Cox比例风险模型计算并比较5年累积发生率和风险。
主要发现
- 匹配后TEVAR组再次血管内干预发生率为27.1%,开放手术组为4.8%,P=0.009。
- TEVAR组其他结局(死亡、再次干预、主动脉夹层、肾衰竭、卒中、颅内出血、截瘫、肢体缺血)的发生率和风险数值上更高,但差异无统计学显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data on the efficacy of endovascular thoracic endovascular aneurysm repair (TEVAR) versus open surgical repair for chronic aortic pathology in patients with connective tissue disorders are limited. In particular, few studies have examined outcomes of TEVAR versus open repair for intact descending thoracic aortic aneurysms (DTAA) in this subset of patients beyond index hospitalization. Therefore, we investigate 5-year outcomes of TEVAR and open surgical repair of intact DTAAs in patients with known connective tissue disorders. METHODS: Using the TriNetX Data Network, a global federated database of over 75 million patients, we conducted a retrospective cohort study of patients with connective tissue disorders and intact DTAAs, treated initially with either TEVAR or open surgery. Eligible patients were 1:1 propensity score-matched for several preoperative co-variates including demographics, surgical history, and comorbidities. We calculated and compared 5-year cumulative incidence and hazards of death, re-intervention, aortic dissection, renal failure, stroke, intracranial hemorrhage, paraplegia, and limb ischemia using the Kaplan-Meier method and Cox proportional hazards models. RESULTS: We identified 55 patients treated with TEVAR and 200 treated with open surgery. After matching, we compared 46 patients in each cohort. After matching, only incidence of re-intervention via endovascular approach was significantly higher among patients in the TEVAR cohort (27.1% vs. 4.8%, P = 0.009). Rates and hazards of other outcomes were higher in the TEVAR group, however, differences were not statistically significant. CONCLUSIONS: Patients treated with TEVAR had numerically higher rates of adverse outcomes compared to open surgical patients, however only the difference in re-intervention rate was statistically significant. Given the evolving landscape of endovascular intervention, greater-powered studies are needed to determine the safety and efficacy of TEVAR for intact DTAAs in a select subset of connective tissue disorder patients.
引用
- Muncan B, Sangari A, Liu SH, et al. Midterm Outcomes of Endovascular Versus Open Surgical Repair of Intact Descending Thoracic Aneurysms in Patients with Connective Tissue Disorders. Ann Vasc Surg. 2022. PMID: 35460854. doi:10.1016/j.avsg.2022.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。